Exploitation of Neisseria Meningitidis Group B OMV Vaccines Against N. Gonorrhoeae to Inform the Development and Deployment of Effective Gonorrhea Vaccines

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.00683
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Challenges for the Development of Vaccines Against Haemophilus Influenzae and Neisseria Meningitidis

Current Opinion in Immunology
AllergyImmunology
2002English

Commentary: Impact of Meningococcal Group B OMV Vaccines, Beyond Their Brief

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2017English

The Comparative Population Genetics of Neisseria Meningitidis and Neisseria Gonorrhoeae

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2019English

Vaccine Development Against Neisseria Meningitidis

Microbial Biotechnology
Applied MicrobiologyBiotechnologyBiochemistryBioengineering
2010English

Vaccine-Induced Opsonophagocytic Immunity to Neisseria Meningitidis Group B

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2008English

The Development of Novel Vaccines Against Tuberculosis

Japanese Journal of Clinical Immunology
2008English

Development of Novel Vaccines Against Human Cytomegalovirus

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2019English

Population Implications of the Deployment of Novel Universal Vaccines Against Epidemic and Pandemic Influenza

Journal of the Royal Society Interface
BiochemistryBiophysicsBiomaterialsBiotechnologyBioengineeringBiomedical Engineering
2020English

Recent Advances in the Development of Vaccines Against Ricin

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy